Congress wants to cut $1.5 trillion from innovative companies and threaten the loss of one million jobs in order to fund a multi-trillion-dollar spending bill, according to Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl. This approach would undermine the ability to develop new treatments and jeopardize patient access to life-saving medicines.
Read More
Cigna Requiring COVID-19 Vaccinations or Testing for Employees Entering U.S. Worksites
August 22nd 2021With confirmed cases of COVID-19 on the rise in the United States, Cigna has established new requirements to help protect its workforce. Employees who work remotely must be fully vaccinated before entering any U.S. worksite, beginning September 7.
Read More
Best Practices to Define, Care for Lung Cancer
July 19th 2021When wondering what step to take first after learning of your cancer diagnosis, assembling the right care team and creating a treatment plan designed uniquely is important to get you on the right track. Comprehensive biomarker testing can then help identify your type of lung cancer and help move steps forward for proper care.
Read More
Multisystem Inflammatory Syndrome in Children (MIS-C) significantly affected more Black and Latino children than white children, with Black children at the highest risk, according to a new observational study of 124 pediatric patients treated at Children's National Hospital in Washington, D.C.
Read More
Medicaid, not Medicare, Is Where the Action Is So Far in the Biden Administration
June 25th 2021The administration seems more interested in using Medicaid than Medicare as a tool for extending health insurance coverage to more Americans, notwithstanding all the debate about Medicare for all last year.
Read More
Half of Latinx, Black Medicare Beneficiaries Choose Medicare Advantage
June 24th 2021Fifty-three percent of Latinx and 49% of Black Medicare beneficiaries choose enrollment in Medicare Advantage; seeing average annual savings of $1,113 and $1,270, respectively, compared to Traditional Medicare.
Read More
In this part five series, participants give their opinions on which drugs newer to the market in the last 12 months hold the most promise to reducing morbidity and mortality. Participants also shared which drug in the pipeline holds the most promise. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.
Read More
In this part four series, participants give their opinions on the biggest driver of specialty drug expenditures this year and what the most significant change in contracts between plan sponsors and PBMs could be in the near future. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next few days.
Read More
Birth Control is Also Part of Sexual Health
June 14th 2021According to the CDC, use of any contraception has remained stable in the United States. From 2015 to 2017, approximately 2 out of 3 girls and women ages 15 to 49 used some form of contraception,and a similar proportion did so from 2017 to 2019.
Read More
2021 Managed Healthcare Executive® Pharmacy Survey: Lasting Effects of the Pandemic
June 11th 2021In this part two series, participants give their opinions on the lasting effects of the pandemic. MHE's annual pharmacy survey had over 225 respondents. We will be posting the results over the next several days.
Read More
Most Americans Support Medicare Negotiation for Drug Prices Despite Claims of Hurting Innovation
June 8th 2021According to a new West Health/Gallup survey, less than 20% of all Americans believe Medicare negotiation would hurt innovation or market competition, including a minority of Republicans.
Read More